Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
Nanocurcumin restores aberrant miRNA expression profile in multiple sclerosis, randomized, double-blind, placebo-controlled trial.
J Cell Physiol. 2018 Jul;233(7):5222-5230. doi: 10.1002/jcp.26301. Epub 2018 Jan 19.
J Cell Physiol. 2018.
PMID: 29194612
Clinical Trial.
Safety and efficacy of fingolimod in Iranian patients with relapsing-remitting multiple sclerosis: An open-label study.
Doosti R, Naser Moghadasi A, Azimi AR, Karbalai Saleh S, Etemadifar M, Shaygannejad V, Ashtari F, Harirchian MH, Siroos SB, Ayramloo H, Majdinasab N, Hojjati SMM, Asghari N, Baghbanian SM, Cheraghmakani H, Abedini M, Sedighi B, Mohseni Abbas Abadi N, Ghasemitabar M, Talebianpour S, Babayi Daylari T, Dana V, Ghaleh Noie N, Sahraian MA.
Doosti R, et al. Among authors: ayramloo h.
Caspian J Intern Med. 2021 Apr;12(3):263-274. doi: 10.22088/cjim.12.3.263.
Caspian J Intern Med. 2021.
PMID: 34221275
Free PMC article.
Item in Clipboard
Iranian Consensus Recommendations for Treatment of Myasthenia Gravis.
Nafissi S, Okhovat AA, Sinaei F, Ansari B, Ayramloo H, Basiri K, Boostani R, Haghi Ashtiani B, Sarraf P, Fatehi F.
Nafissi S, et al. Among authors: ayramloo h.
Arch Iran Med. 2022 Jan 1;25(1):37-49. doi: 10.34172/aim.2022.07.
Arch Iran Med. 2022.
PMID: 35128911
Free article.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.